The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing ...

Genetic differences that contribute to how long a person will live and their risk of Alzheimer's disease have been identified ...

For many years, platinum-based chemotherapy has been one of the mainstays for advanced testicular cancer. Painful peripheral neuropathy, especially in the hands and feet, is a common side effect.

Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

In this prognostic study, with the use of a statistical modeling approach, the Florey Dementia Index was developed and validated to ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

A study has found cardiovascular conditions such as high blood pressure and diabetes, which are known to contribute to brain blood vessel damage in younger populations, not to be associated with an ...

A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...

Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.

Recent studies implicate the immune system and a herpes virus as potential contributors to development of the disease.